Bolloré Logistics has created a task force to design cold chain solutions for the distribution of Covid-19 vaccines as soon as they are marketed.
The temperature-controlled transport of Covid-19 vaccines, estimated to total 15bn doses* worldwide, is a major challenge, as some of them will need to be kept at a temperature between +2°C and +8°C and others at a very low temperature of around -70°C.
Because of this, Bolloré Logistics is planning ahead and preparing all possible scenarios, including active and passive packaging solutions.
The France-based global logistics operator has for many years invested in infrastructures, human resources and technologies to boost its capacities in the health sector.
Bolloré Logistics global chief commercial officer Olivier Boccara said: “Ahead of the marketing of Covid-19 vaccines, we have rallied all our skills and resources to meet the logistics challenges to come.
“We are ready to play our full role in the global distribution of the future vaccines alongside all the players concerned, particularly pharmaceutical laboratories and international organisations.”
The company, which has obtained CEIV pharma certification, will rely on its own resources as well as those of its existing subcontractors to transport vaccines by air in respect of the cold chain.
Supplementing the solutions, Bolloré Logistics’ collaborative platform will provide complete visibility of the supply chain and, via the healthcare control tower available 24/7, address any potential issues (including delays, temperature differences and damage).
*Source: Seabury.
